← Back

Why AI startups are selling the same equity at two different prices

Some AI founders are using a novel valuation mechanism to manufacture unicorn status.

---

Related Articles

• Drug regulator to rope in external agencies to inspect units
• Battered and Bruised, Spurs 'Trust' Themselves Past the Trade Deadline
• Current Health Headlines: New Moves in Medical Education, Drug Production, and FDA Warnings
• Priyanka Chopra Jonas reveals she was “forced” to announce daughter’s birth during her NICU battle: “We didn’t know what would happen with her”

Source: Original →